医学研究生学报
醫學研究生學報
의학연구생학보
JOURNAL OF MEDICAL POSTGRADUATE
2014年
9期
940-944
,共5页
急性肠系膜上静脉血栓%急性肠系膜缺血%肠系膜血管再通%肠系膜动%静脉联合导管溶栓
急性腸繫膜上靜脈血栓%急性腸繫膜缺血%腸繫膜血管再通%腸繫膜動%靜脈聯閤導管溶栓
급성장계막상정맥혈전%급성장계막결혈%장계막혈관재통%장계막동%정맥연합도관용전
Acute superior mesenteric venous thrombosis%Acute mesenteric ischemia%Mesenteric vascular recanalization%Superior mesenteric artery%Transcatheter thrombolysis via superior artery and vein
目的:导管溶栓治疗是急性肠系膜上静脉血栓实现早期血管再通的重要手段,主要有经皮经肝穿刺门静脉或经颈静脉门体分流道直接溶栓及经肠系膜上动脉间接溶栓3种途径。文中评估了肠系膜上动、静脉联合导管溶栓治疗急性肠系膜上静脉广泛血栓的临床疗效及安全性。方法回顾性分析2011年5月至2012年7月解放军普通外科研究所应用肠系膜上动、静脉联合导管溶栓疗法治疗8名急性肠系膜上静脉广泛血栓患者。对患者的一般信息、病史、病因、危险因素、影像资料、治疗过程、并发症及随访资料进行整理和分析,总结肠系膜上动、静脉联合导管溶栓治疗急性肠系膜上静脉广泛血栓的相关经验。结果8名患者成功完成溶栓导管置入后分别经肠系膜上动、静脉持续给予磺达肝葵钠注射液局部抗凝及尿激酶溶栓,其中动脉注射平均(6.13±0.83)d、静脉注射平均(12.00±2.51)d。8名患者溶栓后症状均得到明显缓解。4名患者溶栓后行二次探查手术并给予损伤控制性外科处理,平均切除肠袢(1.63±0.48)m,术后进入重症监护给予液体复苏及器官功能支持后恢复良好。出院前门静脉造影及增强CT扫描证实血栓完全溶解,平均住院时间(19.25±4.89) d。治疗过程中2例出现脓毒症、2例发生穿刺点轻微出血。所有患者在出院后平均(12.13±0.99)个月的随访中,无血栓复发及其他并发症发生。结论对于急性肠系膜上静脉广泛血栓患者,肠系膜上动、静脉联合导管溶栓治疗可以加快症状缓解及血栓溶解,促进侧支血管形成,积极扭转缺血肠袢,有效避免广泛肠切除引起短肠综合症的发生,促进患者早期康复,有效提高整体生存率。
目的:導管溶栓治療是急性腸繫膜上靜脈血栓實現早期血管再通的重要手段,主要有經皮經肝穿刺門靜脈或經頸靜脈門體分流道直接溶栓及經腸繫膜上動脈間接溶栓3種途徑。文中評估瞭腸繫膜上動、靜脈聯閤導管溶栓治療急性腸繫膜上靜脈廣汎血栓的臨床療效及安全性。方法迴顧性分析2011年5月至2012年7月解放軍普通外科研究所應用腸繫膜上動、靜脈聯閤導管溶栓療法治療8名急性腸繫膜上靜脈廣汎血栓患者。對患者的一般信息、病史、病因、危險因素、影像資料、治療過程、併髮癥及隨訪資料進行整理和分析,總結腸繫膜上動、靜脈聯閤導管溶栓治療急性腸繫膜上靜脈廣汎血栓的相關經驗。結果8名患者成功完成溶栓導管置入後分彆經腸繫膜上動、靜脈持續給予磺達肝葵鈉註射液跼部抗凝及尿激酶溶栓,其中動脈註射平均(6.13±0.83)d、靜脈註射平均(12.00±2.51)d。8名患者溶栓後癥狀均得到明顯緩解。4名患者溶栓後行二次探查手術併給予損傷控製性外科處理,平均切除腸袢(1.63±0.48)m,術後進入重癥鑑護給予液體複囌及器官功能支持後恢複良好。齣院前門靜脈造影及增彊CT掃描證實血栓完全溶解,平均住院時間(19.25±4.89) d。治療過程中2例齣現膿毒癥、2例髮生穿刺點輕微齣血。所有患者在齣院後平均(12.13±0.99)箇月的隨訪中,無血栓複髮及其他併髮癥髮生。結論對于急性腸繫膜上靜脈廣汎血栓患者,腸繫膜上動、靜脈聯閤導管溶栓治療可以加快癥狀緩解及血栓溶解,促進側支血管形成,積極扭轉缺血腸袢,有效避免廣汎腸切除引起短腸綜閤癥的髮生,促進患者早期康複,有效提高整體生存率。
목적:도관용전치료시급성장계막상정맥혈전실현조기혈관재통적중요수단,주요유경피경간천자문정맥혹경경정맥문체분류도직접용전급경장계막상동맥간접용전3충도경。문중평고료장계막상동、정맥연합도관용전치료급성장계막상정맥엄범혈전적림상료효급안전성。방법회고성분석2011년5월지2012년7월해방군보통외과연구소응용장계막상동、정맥연합도관용전요법치료8명급성장계막상정맥엄범혈전환자。대환자적일반신식、병사、병인、위험인소、영상자료、치료과정、병발증급수방자료진행정리화분석,총결장계막상동、정맥연합도관용전치료급성장계막상정맥엄범혈전적상관경험。결과8명환자성공완성용전도관치입후분별경장계막상동、정맥지속급여광체간규납주사액국부항응급뇨격매용전,기중동맥주사평균(6.13±0.83)d、정맥주사평균(12.00±2.51)d。8명환자용전후증상균득도명현완해。4명환자용전후행이차탐사수술병급여손상공제성외과처리,평균절제장번(1.63±0.48)m,술후진입중증감호급여액체복소급기관공능지지후회복량호。출원전문정맥조영급증강CT소묘증실혈전완전용해,평균주원시간(19.25±4.89) d。치료과정중2례출현농독증、2례발생천자점경미출혈。소유환자재출원후평균(12.13±0.99)개월적수방중,무혈전복발급기타병발증발생。결론대우급성장계막상정맥엄범혈전환자,장계막상동、정맥연합도관용전치료가이가쾌증상완해급혈전용해,촉진측지혈관형성,적겁뉴전결혈장번,유효피면엄범장절제인기단장종합증적발생,촉진환자조기강복,유효제고정체생존솔。
Objective Transcatheter thrombolysis is an important method for early recanalization of acute superior mesenteric venous thrombosis (SMVT), which is conducted mainly through percutaneous transhepatic , transjugular intrahepatic, or superior mesen-teric artery approach .This study is to assess the feasibility , effectiveness and safety of catheter-directed thrombolysis via the superior mesenteric vein and artery for acute SMVT . Methods We retrospectively reviewed 8 cases of acute extensive SMVT treated by tran-scatheter thrombolysis via superior mesenteric vein and artery in our institute .We collected and analyzed the general information , case history, etiology, risk factors, imaging characteristics, treatment procedures, complications, and follow-up data of the patients summa-rized the experience in the treatment of acute extensive SMVT by catheter-directed thrombolysis . Results Technical success was a-chieved with substantial symptoms improvement after thrombolytic therapy in all the cases .The local urokinase infusion via the superior mesenteric artery and vein was performed for (6.13 ±0.83) and (12 ±2.51) d.Four patients required delayed localized bowel resection of (1.63 ±0.48) m, with satisfactory recovery after intensive care and organ function support .Contrast-enhanced CT scan and portogra-phy demonstrated complete thrombus resolution in all the patients before discharged after a hospital stay of (19.25 ±4.89) d.Minor bleeding at the puncture site occurred in 2 cases and sepsis developed in another 2 postoperatively .No recurrence and complications were ob-served during the follow-up of (12.13 ±0.99) mo. Conclusion For acute extensive SMVT , catheter-directed thrombolytic therapy via superior mesenteric vein and artery can accelerate thrombus resolution , stimulate collateral vessel development , reverse extensive intestinal is-chemia, avert bowel resection , localize infarcted bowel segment to pre-vent short bowel syndrome , and effectively speed up the recovery and significantly increase the survival rate of the patients .